Answers are grounded in this paper and cite their sources.
Observes the lack of alloantibody production in neonates, suggesting fewer transfusion tests are needed.
Red blood cell alloantibody production was studied in 90 neonates who received a mean of 14.1 transfusions (range 2-35) from an average of 8.9 donors during the first three months after birth. Standard antibody detection procedures were done with the use of a selected red blood cell panel. No unexpected alloantibodies were detected. These findings suggest, at a 99% confidence level, that neonates do not make red blood cell alloantibodies in response to transfusion, indicating that repeated compatibility testing is probably unnecessary. Thus, following initial antibody screening and compatibility tests, further compatibility testing can be eliminated.
No takes yet. Share an insight, caveat, or question.
Ludvigsen et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: